National Trends in Healthcare Expenditures for the Management of Skin Cancer in the United States.

ABSTRACT:

Background

Malignant melanoma and keratinocyte carcinomas account for a substantial proportion of healthcare expenditures in the United States.

Objective

To estimate trends in the economic burden of skin cancer in the United States between 1996 and 2016.

Methods

The Disease Expenditure Project and Global Burden of Disease databases were used to estimate annual total costs and population-standardized rates of change for skin cancer-related healthcare spending.

Results

Skin cancer expenditures totaled $23.4 billion in 2016, of which $1.4 billion (95% CI: $1.3-$1.6 billion) was melanoma-related and $22 billion (95% CI: $18-$28 billion) was keratinocyte carcinoma-related. Most spending on skin cancer management occurred in ambulatory care settings [60.7% (95% CI: 5

SUBMITTER: Ma B 

PROVIDER: S-EPMC11829503 | biostudies-literature | 2025 Jan-Feb

REPOSITORIES: biostudies-literature